Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
clinical trials
fda
5
×
life sciences
national blog main
boston blog main
boston
boston top stories
deals
investing
national top stories
san francisco blog main
new york blog main
san francisco top stories
480 biomedical
abbvie
aimmune therapeutics
akouos
allergan
allergy
amgen
anaphylaxis
andrew oxtoby
arsenal medical
astellas pharmaceuticals
biofourmis
biohaven
biovotion
bob langer
boulder/denver blog main
boulder/denver top stories
california institute for biomedical research
cgpr
chronic rhinosinusitis
chugai pharmaceutical
covid-19
daniel edelman
decibel therapeutics
detroit blog main
detroit top stories
What
treat
5
×
therapeutics
approved
fda
developing
drug
ipo
late
medicines
million
new
raised
adults
affects
agency
aimmune
allergan
allergy
americans
analytics
approval
awarded
biofourmis
biotech
class
company
data
date
debut
developed
devices
digital
employs
frequency
friday
globally
hauls
hearing
help
immunotherapy
Language
unset
Current search:
fda
×
biotech
×
treat
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
